Natick, MA - Boston Scientific Corp announced that the FDA has approved its FilterWire EZ ® Embolic Protection System for use in the treatment of saphenous vein graft (SVG) disease. The company plans ...

December 15, 2006 (Natick, MA) - The US FDA has granted marketing clearance for the FilterWire EZ embolic-protection system for use in carotid stenting, the manufacturer, Boston Scientific, announced ...

Natick-based Boston Scientific Corp. has been given the go-ahead from the U.S. Food and Drug Administration to market its FilterWire EX Embolic Protection System to treat saphenous vein graft (SVG) ...

DUBLIN--(BUSINESS WIRE)--The "Global and Chinese Embolic protection systems Industry, 2018 Market Research Report" report has been added to ResearchAndMarkets.com's offering. This report provides key ...

CHICAGO, IL—Cerebral embolic protection devices are infrequently used during transcatheter aortic valve implantation procedures in the United States, and new data suggest their use does not appear to ...

DUBLIN--(BUSINESS WIRE)--The "Embolic Protection Devices Market by Type (Distal Filter, Distal Occlusion, Proximal Occlusion), Material (Nitinol, Polyurethane ...

Austin, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Embolic Protection Devices Market Size and Growth Analysis: According to SNS Insider, the global Embolic Protection Devices Market was valued at USD 656.60 ...

Please provide your email address to receive an email when new articles are posted on . How many randomized clinical trials of parachutes vs. no parachutes are there? The answer, of course, is none.

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...